In the context of severe viral infections like COVID-19, pathways involving inflammatory cytokines and chemokines, such as IL-6, IL-1β, and TNF-α, are significantly elevated, contributing to cytokine release syndrome (CRS) [96]. This evidence concerns the gene IL6 and viral infectious disease.